Yan Wang

Yan leads the in vivo biology efforts at BioAge and contributes to preclinical strategy, vision, operation, and investigation. The team develops high quality and reproducible animal models using preclinical aging platform to investigate small molecule and biologic therapeutics on aging and aging-related indications. Yan has 12 publications and 7+ patents with expertise in preclinical research of oncology, metabolic diseases, inflammatory diseases, pulmonary diseases, and autoimmune diseases. Prior to BioAge, Yan was the Director of In-Vivo Biology/Translational Medicine at TrueBinding Inc. leading the preclinical in vivo efforts for antibody drug discovery and development. Yan received her B.S. in Pharmaceutical Science from China Pharmaceutical University, PhD in Pharmaceutical Sciences from University of Nebraska Medical Center and postdoctoral training from University of California San Francisco.